PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91020F00010Initiate the management — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. PoP ended Apr 2, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nih Nci
Awarding office
Department of Health and Human Services (HHS)
Agency
Leidos Biomedical Research, Inc
Recipient
Apr 2, 2025
PoP end
$-11,000,000
Obligated
541715
NAICS
AN12
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75N91020F00010
Also listed as75N91019D00024-75N91020F00010
AgencyDepartment of Health and Human Services (HHS)
Awarding officeNih Nci
IncumbentLeidos Biomedical Research, Inc
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK, MD
PoP end (current)Apr 2, 2025
Obligated$-11,000,000

INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDO… is a federal award for Department of Health and Human Services (HHS) held by Leidos Biomedical Research, Inc. Estimated value $83.4M ($-11,000,000 obligated). Current period of performance ends Apr 2, 2025. Place of performance: FREDERICK, MD.

INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19".

Recompete timing

Public
● Past PoP end (546 days ago)

Current PoP ended Apr 2, 2025 (546 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75N91020F00010? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Leidos Biomedical Research, Inc — $2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.1B · 100% of firm total
Open full company profile →

Related awards

Same parent · incumbent
75N91020F00026
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$56.5M
May 25, 2027
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$92.1M
Feb 28, 2028
75N91020F00009
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$89.6M
Jul 31, 2028
75N91020F00025
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT,…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$97.5M
Sep 24, 2028
75N91020F00039
NIAID COVID-19 ACTIV3
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$281.6M
Sep 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91020F00010?

75N91020F00010 (Initiate the management) is a Nih Nci award with an estimated value of $83.4M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91020F00010?

Nih Nci awarded 75N91020F00010 to Leidos Biomedical Research, Inc.

Who is the incumbent on 75N91020F00010?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Apr 2, 2025.

When does Leidos Biomedical Research, Inc’s 75N91020F00010 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 2, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N91020F00010? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91020F00010